943
Views
11
CrossRef citations to date
0
Altmetric
Psychiatry

A meta-analysis of the efficacy of venlafaxine extended release 75–225 mg/day for the treatment of major depressive disorder

, , , , &
Pages 317-326 | Received 09 May 2016, Accepted 27 Oct 2016, Published online: 28 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Andrea Fagiolini, Narcis Cardoner, Sebnem Pirildar, Pichai Ittsakul, Bernardo Ng, Kalil Duailibi & Nasser El Hindy. (2023) Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder. Expert Opinion on Pharmacotherapy 24:15, pages 1715-1723.
Read now
Shuai Shao, Yu Cui, Zhao-Bin Chen, Bo Zhang, Shu-Ming Huang & Xue-Wei Liu. (2020) Androgen deficit changes the response to antidepressant drugs in tail suspension test in mice. The Aging Male 23:5, pages 1259-1265.
Read now

Articles from other publishers (9)

E. Madrigal-Bujaidar, P. Gómez-González, S. Camacho-Cantera, J. A. Morales-González, E. Madrigal-Santillán & I. Álvarez-González. (2024) Genotoxic and cytotoxic evaluation of venlafaxine in an acute and a subchronic assay in mouse. Brazilian Journal of Biology 84.
Crossref
Rong Yang, Lu Wang, Kun Jin, Song Cao, Chujun Wu, Jimin Guo, Jindong Chen, Hui Tang & Mimi Tang. (2022) Omega-3 Polyunsaturated Fatty Acids Supplementation Alleviate Anxiety Rather Than Depressive Symptoms Among First-Diagnosed, Drug-Naïve Major Depressive Disorder Patients: A Randomized Clinical Trial. Frontiers in Nutrition 9.
Crossref
Gerd Laux & Ansgar Klimke. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 27 .
Gerd Laux & Ansgar Klimke. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1319 1345 .
Masaki Kato, Yuko Asami, Dalia B. Wajsbrot, Xuemei Wang, Matthieu Boucher, Rita Prieto & Elizabeth Pappadopulos. (2020) Clustering patients by depression symptoms to predict venlafaxine ER antidepressant efficacy: Individual patient data analysis. Journal of Psychiatric Research 129, pages 160-167.
Crossref
Martin A Katzman, Xuemei Wang, Dalia B Wajsbrot & Matthieu Boucher. (2020) Effects of desvenlafaxine versus placebo on MDD symptom clusters: A pooled analysis. Journal of Psychopharmacology 34:3, pages 280-292.
Crossref
Nadine El-Ayache & James J. Galligan. 2020. The Laboratory Rat. The Laboratory Rat 1003 1022 .
Gavin J. Lyndon, Rita Prieto, Dalia B. Wajsbrot, Christer Allgulander & Borwin Bandelow. (2019) Efficacy of venlafaxine extended release in major depressive disorder patients. International Clinical Psychopharmacology 34:3, pages 110-118.
Crossref
Ryosuke Arakawa, Per Stenkrona, Akihiro Takano, Jonas Svensson, Max Andersson, Sangram Nag, Yuko Asami, Yoko Hirano, Christer Halldin & Johan Lundberg. (2019) Venlafaxine ER Blocks the Norepinephrine Transporter in the Brain of Patients with Major Depressive Disorder: a PET Study Using [18F]FMeNER-D2. International Journal of Neuropsychopharmacology 22:4, pages 278-285.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.